Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa

Gut

Volumn 44, Issue 5, 1999, Pages 629-635

  Wedemeyer, J ^a   Lorentz, A c ^a   Goke, M ^a   Meier, P N ^a   Flemming, P ^a   Dahinden, C A ^b   Manns, M P ^a   Bischoff, S C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Chemokines; Crohn's disease; Epithelial cells; Monocyte chemotactic protein 3; Ulcerative colitis

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INTESTINE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033005736     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.5.629     Document Type: Article

References (39)

1. 1 Adams DH, Lloyd AR. Chemokines: leukocyte recruitment and activation cytokines. Lancet 1997;349:490-5.
2. 2 Colletti LM, Kunkel SL, Walz A, et al. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. J Clin Invest 1995;95:134-41.
3. 3 Gillitzer R, Ritter U, Spandau U, et al. Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol 1996;107:778-82.
4. 4 Kunkel SL, Lukacs N, Kasama T, et al. The role of chemokines in inflammatory joint disease. J Leukoc Biol 1996;59: 6-12.
5. 5 Brown Z, Robson RL, Westwick J. Regulation and expression of chemokines: potential role in glomerulonephritis. J Leukoc Biol 1996;59:75-80.
6. 6 Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
7. 7 Feng Y, Broder CC, Kennedy PE, et al. HIV-1 entry cofactor-functional cDNA cloning of a 7-transmembrane, G-protein-coupled receptor. Science 1996;272:872-7.
8. 8 Baggiolini M, Dewald D, Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol 1994;55:97-179.
9. 9 Rollins BJ. Chemokines. Blood 1997;90:909-28.
10. 10 Reinecker HC, Loh EY, Ringler DJ, et al. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial colls and inflammatory bowel disease mucosa. Gastroenterology 1995;108:40-50.
11. 11 Grimm MC, Elsbury SKO, Pavli P, et al. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukoc Biol 1996;59:804-12.
12. 12 Mazzucchelli L, Hauser C, Zgraggen K, et al. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J Pathol 1996;178:201-6.
13. 13 Van Damme J, Proost P Lenaerts JP, et al. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med 1992;176: 59-65.
14. 14 Opdenakker G, Froyen G, Fiten P, et al. Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. Biochem Biophys Res Commun 1993;191:535-42.
15. 15 Xu LL, McVicar DW, Ben-Baruch A, et al. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur J Immunol 1995;25:2612-7.
16. 16 Taub DD, Proost P, Murphy WJ, et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995;95:1370-6.
17. 17 Dahinden CA, Geiser T, Brunner T, et al. Monocyte chemotactic protein 3 is a most effective basophil-and eosinophil-activating chemokine. J Exp Med 1994;179: 751-6.
18. 18 Humbert M, Ying S, Corrigan C, et al. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (TL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am J Respir Cell Mol Biol 1997;16:1-8.
19. 19 Powell N, Humbert M, Durham SR, et al. Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur Respir J 1996;9: 2454-60.
20. 20 Bischoff SC, Schwengberg S, Raab R, et al. Functional properties of human intestinal mast cells cultured in a new culture system. Enhancement of IgE receptor-dependent mediator release and response to stem cell factor. J Immunol 1997;159:5560-7.
21. 21 Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996;28:1-13.
22. 22 Göke M, Kanai M, Podolsky DK. Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor. Am J Physiol 1998;274:809-18.
23. 23 Murgue B, Tsunekawa S, Rosenberg I, et al. Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium. Cancer Res 1994;54:5206-11.
24. 24 Kindon H, Pothoulakis C, Thim L, et al. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995;109:516-23.
25. 25 Wong H, Anderson WD, Cheng T, et al. Monitoring mRNA expression by polymerase chain reaction: the "primer dropping" method. Anal Biochem 1994;223:251-8.
26. 26 Sanger F, Nicklen S, Coulson AR. DNA sequencing with terminating inhibitors. Proc Natl Acad Sci USA 1977;74: 5463-7.
27. 27 Bischoff SC, Schwengberg S, Wordelmann K, et al. Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease. Gut 1996;38:104-14.
28. 28 Mazzucchelli L, Hauser C, Z'graggen K, et al. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 1994;144:997-1007.
29. 29 Z'graggen K, Walz A, Mazzucchelli L, et al. The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology 1997;113:808-16.
30. 30 Izutani R, Loh EY, Reinecker HC, et al. Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn's disease mucosa and epithelial cells. Inflamm Bowel Dis 1995;1:37-47.
31. 31 Stafford S, Li H, Forsythe PA, et al. Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J Immunol 1997;158:4953-60.
32. 32 Huang GT, Eckman L, Savidge TC, et al. Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM-1) expression and neutrophil adhesion. J Clin Invest 1996;98:572-83.
33. 33 Jung HC, Eckmann L, Yang SK, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995;95:55-65.
34. 34 Eckmann L, Kagnoff MF, Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 1993;61:4569-74.
35. 35 Murch SH, Braegger CP, Walker-Smith JA, et al. Location of tumor necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993;34:1705-9.
36. 36 Murata Y, Ishiguro Y, Itoh J, et al. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gastroenterol 1995;30(suppl 8):56-60.
37. 37 Yang SK, Eckmann L, Panja A, et al. Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 1997;113: 1214-23.
38. 38 Casola A, Estes MK, Crawford SE, et al. Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. Gastroenterology 1998;114:947-55.
39. 39 MaeDermott RP, Sanderson IR, Reinecker HC. The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 1998;4:54-67.